The impact of different brands of covid-19 vaccination on public health outcomes: analyzing the effectiveness and side effects of these vaccines among ksmu students and their perspectives towards covid vaccinations
DOI:
https://doi.org/10.58676/sjmas.v2i10.101Keywords:
Public health outcomes, Medical students' perspectives, Side effects, Vaccine effectiveness, COVID-19 vaccinesAbstract
Background: The COVID-19 pandemic highlighted the critical role of vaccines in reducing infection rates and improving public health outcomes. This study focuses on the impact of different COVID-19 vaccine brands among students at Kursk State Medical University (KSMU). The research investigates vaccine effectiveness in preventing infection, the occurrence of side effects, and medical students’ perspectives regarding vaccination. Understanding these elements is essential to ensure effective vaccination campaigns among future healthcare professionals.
Methods and Materials: A descriptive cross-sectional study was conducted using a structured online questionnaire. The sample comprised 65 foreign medical students from KSMU across various academic levels. The survey included questions on vaccine types, demographics, side effects, infection history, and personal perceptions. Statistical analyses were performed to assess the trends in vaccine effectiveness, side effects, and student attitudes.
Results: Of the 65 respondents, 95.4% were vaccinated with at least one dose, with Pfizer-BioNTech, Sputnik Light, and Sinovac being the most common vaccines. Among vaccinated students, 62.9% reported side effects, including fever, fatigue, and muscle pain. Reinfection occurred in 32.8% of vaccinated participants, predominantly after the third dose. Despite this, 65.1% of students believed vaccines effectively prevent COVID-19, and 98.4% encouraged others to get vaccinated.
Conclusion: The study concludes that COVID-19 vaccines, particularly booster doses, significantly reduce reinfection rates and severity of illness. Mixed and same-brand vaccine regimens demonstrated comparable effectiveness. However, persistent reinfection rates highlight the need for continued public health efforts, including booster campaigns and transparent communication to address hesitancy and misconceptions.
References
World Health Organization. (2022). Clinical management of COVID-19 (1st ed., pp. 1–148). Https://apps.who.int/iris/bitstream/handle/10665/349321/WHO-2019-ncov-Clinical-2022.1-eng.pdf
Coronavirus (COVID-19) vaccinations. (2023). Our World in Data. Retrieved from https://ourworldindata.org/covid-vaccinations
Centers for Disease Control and Prevention. (2019). SARS-cov-2 variants. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html
Centers for Disease Control and Prevention. (2023, February 10). COVID-19 incidence and mortality among unvaccinated and vaccinated persons aged ≥12 years by receipt of bivalent booster doses and time since vaccination — 24 U.S. jurisdictions, October 3, 2021–December 24, 2022. Morbidity and Mortality Weekly Report.
European Medicines Agency. (2021). Sputnik V COVID-19 vaccine approved for use in the European Union. Retrieved from https://www.ema.europa.eu/en/news/sputnik-v-covid-19-vaccine-approved-use-european-union
World Health Organization. (2021, June 1). China's Sinovac COVID-19 vaccine receives WHO validation. Retrieved from https://www.who.int/news/item/01-06-2021-china-s-sinovac-covid-19-vaccine-receives-who-validation
World Health Organization. (2021). Astrazeneca COVID-19 vaccine: What you need to know. Retrieved from https://www.who.int/news-room/feature-stories/detail/astrazeneca-covid-19-vaccine-what-you-need-to-know
Centers for Disease Control and Prevention. (2021). Sputnik V COVID-19 vaccine. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/sputnik.html
Research and Policy. (2020). Global COVID-19 surge strains health systems. Retrieved from https://www.cidrap.umn.edu/news-perspective/2020/11/global-covid-19-surge-strains-health-systems
World Health Organization. (2021). Health workforce. Retrieved from https://www.who.int/health-topics/health-workforce#tab=tab_1
Centers for Disease Control and Prevention. (2021, November 4). Smoking and COVID-19. Retrieved from https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease/need-to-know/index.html
World Health Organization. (2021, October 28). Alcohol and COVID-19: What you need to know. Retrieved from https://www.who.int/emergencies/disease-outbreak-news/item/2020-DON-29October2020-alcohol-and-COVID-19
Centers for Disease Control and Prevention. (2021, November 4). Drinking water. Retrieved from https://www.cdc.gov/healthywater/drinking/nutrition/index.html
BBC News. (2021, January 11). COVID: How has the pandemic affected global birth rates? Retrieved from https://www.bbc.com/news/world-55573686
The World Bank. (2021). Migration and remittances: Recent developments and outlook. The World Bank Group.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Angle Tang Ngiik Ling, Dr Ghassan Salibi, Prof Nikolaos Tzenios
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
